Literature DB >> 11726023

Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations.

S D Pinkerton1.   

Abstract

This study was conducted to answer the question, "Are sexual risk behaviors subject to compensation?" For example, do people who increase their use of condoms compensate for this reduction in human immunodeficiency virus and sexually transmitted disease (HIV/STD) risk by engaging in more overall acts of intercourse or by having sex with more partners than before? Utilizing the HIV prevention literature, studies in which participants demonstrated sexual risk compensation were identified. A simple HIV/STD transmission model was applied to these data to determine whether compensation produced a net increase in HIV/STD risk, despite positive changes in one or more aspects of sexual behavior. Although a number of studies were found in which there were simultaneous increases in condom use and the overall number of acts of intercourse, in none of these instances was there an overall increase in HIV/STD risk. Moreover, none of these studies reported concomitant increases in the number of sex partners. Extensive modeling exercises also were conducted to determine the theoretical conditions under which compensation would produce a net increase in risk. The results of the modeling exercise indicated that relatively small increases in overall sexual activity could be sufficient to offset risk-reduction gains due to increased condom use in populations in which baseline condom use is very low. In sum, although sexual risk compensation occurs, no empirical evidence was found that this compensation is sufficient to offset reductions in risk due to greater condom use, despite the theoretical plausibility of this scenario.

Entities:  

Mesh:

Year:  2001        PMID: 11726023     DOI: 10.1111/0272-4332.214146

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  21 in total

1.  The impact of reduced ignition propensity cigarette regulation on smoking behaviour in a cohort of Ontario smokers.

Authors:  Richard J O'Connor; Brian V Fix; David Hammond; Gary A Giovino; Andrew Hyland; Geoffrey T Fong; K Michael Cummings
Journal:  Inj Prev       Date:  2010-07-19       Impact factor: 2.399

Review 2.  Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions.

Authors:  A M Minnis; N S Padian
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

3.  Sexually transmitted infections in Canada: A sticky situation.

Authors:  David N Fisman; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

4.  Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.

Authors:  J T Galea; J J Kinsler; X Salazar; S-J Lee; M Giron; J N Sayles; C Cáceres; W E Cunningham
Journal:  Int J STD AIDS       Date:  2011-05       Impact factor: 1.359

5.  Perceptions of sexual risk compensation following posttrial HIV vaccine uptake among young South Africans.

Authors:  Catherine L Macphail; Jennifer N Sayles; William Cunningham; Peter A Newman
Journal:  Qual Health Res       Date:  2012-01-04

6.  No evidence that HPV vaccination leads to sexual risk compensation.

Authors:  Bo T Hansen
Journal:  Hum Vaccin Immunother       Date:  2016-03-22       Impact factor: 3.452

7.  Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study.

Authors:  Rafael E Pérez-Figueroa; Farzana Kapadia; Staci C Barton; Jessica A Eddy; Perry N Halkitis
Journal:  AIDS Educ Prev       Date:  2015-04

8.  "When I was circumcised I was taught certain things": risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya.

Authors:  Thomas H Riess; Maryline M Achieng'; Samuel Otieno; J O Ndinya-Achola; Robert C Bailey
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.

Authors:  Sarah K Calabrese; Valerie A Earnshaw; Kristen Underhill; Nathan B Hansen; John F Dovidio
Journal:  AIDS Behav       Date:  2014-02

10.  Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Authors:  G E Gray; B Metch; G Churchyard; K Mlisana; M Nchabeleng; M Allen; Z Moodie; J Kublin; L-G Bekker
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.